risperidone 1mg/ml oral solution
pinewood laboratories ltd, - risperidone - oral solution - 1 milligram(s)/millilitre - other antipsychotics; risperidone
reminyl 4 mg/ml oral solution
takeda pharmaceuticals international ag ireland branch - galantamine hydrobromide - oral solution - 4 milligram(s)/millilitre - anticholinesterases; galantamine
risperdal oral solution 1 mgml
johnson & johnson international (singapore) pte ltd - risperidone - solution - 1 mg/ml - risperidone 1 mg/ml
risperidone 1mg/ml oral solution
rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.
risperidone 1mg/ml oral solution sugar free
sandoz ltd - risperidone - oral solution - 1mg/1ml
3tc lamivudine 10mg/ml oral liquid solution bottle
viiv healthcare pty ltd - lamivudine, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: citric acid; sodium hydroxide; propyl hydroxybenzoate; purified water; hydrochloric acid; sodium citrate dihydrate; methyl hydroxybenzoate; propylene glycol; sucrose; flavour - 3tc (lamivudine) in combination with other antiretroviral agents is indicated for the treatment of hiv infected adults and children.
risperdal risperidone 1mg/ml oral liquid bottle
janssen-cilag pty ltd - risperidone, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: purified water; benzoic acid; tartaric acid; sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and related psychoses. risperdal is indicated for the short term treatment of acute mania associated with bipolar 1 disorder. risperdal is also indicated for the treatment of behavioural disturbances in dementia. risperdal is indicated in the treatment of conduct and other disruptive behaviour disorders in children (over 5 years), adolescents and adults with sub-average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent (see clinical trials for maintenance data). risperdal is indicated for the treatment of behavioural disorders associated with autism in children and adolescents (see clinical trials).
risperidone oral solution 1mg/ml
syri limited - risperidone - oral solution - risperidone 1 mg/ml - psycholeptics
risperdal oral solution
janssen inc - risperidone (risperidone tartrate) - solution - 1mg - risperidone (risperidone tartrate) 1mg - atypical antipsychotics
lamivudine oral solution
aurobindo pharma limited (unit iii) - lamivudine - solution - 10mg - lamivudine 10mg - nucleoside and nucleotide reverse transcriptase inhibitors